ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 125 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,073 | -73.9% | 15,731 | +1.0% | 0.00% | – |
| Q2 2023 | $7,941 | -24.4% | 15,570 | -6.6% | 0.00% | – |
| Q1 2023 | $10,500 | -18.6% | 16,667 | -16.2% | 0.00% | – |
| Q4 2022 | $12,906 | -58.4% | 19,883 | +9.3% | 0.00% | – |
| Q3 2022 | $31,000 | +47.6% | 18,186 | +8.1% | 0.00% | – |
| Q2 2022 | $21,000 | -48.8% | 16,818 | -72.7% | 0.00% | – |
| Q1 2022 | $41,000 | -50.6% | 61,668 | -19.1% | 0.00% | – |
| Q4 2021 | $83,000 | -37.6% | 76,236 | +4.6% | 0.00% | – |
| Q3 2021 | $133,000 | -45.9% | 72,914 | -21.7% | 0.00% | -100.0% |
| Q2 2021 | $246,000 | -21.2% | 93,105 | +7.5% | 0.00% | 0.0% |
| Q1 2021 | $312,000 | +54.5% | 86,618 | +7.9% | 0.00% | 0.0% |
| Q4 2020 | $202,000 | +206.1% | 80,295 | +207.3% | 0.00% | – |
| Q3 2020 | $66,000 | -30.5% | 26,132 | -9.8% | 0.00% | -100.0% |
| Q2 2020 | $95,000 | +265.4% | 28,973 | +168.2% | 0.00% | – |
| Q1 2020 | $26,000 | -74.8% | 10,803 | -50.4% | 0.00% | – |
| Q4 2019 | $103,000 | +32.1% | 21,763 | +19.0% | 0.00% | – |
| Q3 2019 | $78,000 | -3.7% | 18,285 | +31.2% | 0.00% | – |
| Q2 2019 | $81,000 | +47.3% | 13,941 | -2.6% | 0.00% | – |
| Q1 2019 | $55,000 | +111.5% | 14,307 | +3.2% | 0.00% | – |
| Q4 2018 | $26,000 | -50.0% | 13,861 | -13.9% | 0.00% | – |
| Q3 2018 | $52,000 | 0.0% | 16,096 | -7.1% | 0.00% | – |
| Q2 2018 | $52,000 | -21.2% | 17,331 | +3.2% | 0.00% | – |
| Q1 2018 | $66,000 | -18.5% | 16,794 | -13.9% | 0.00% | -100.0% |
| Q4 2017 | $81,000 | +12.5% | 19,505 | +68.0% | 0.00% | 0.0% |
| Q2 2017 | $72,000 | -19.1% | 11,608 | -17.0% | 0.00% | 0.0% |
| Q1 2017 | $89,000 | -14.4% | 13,990 | -28.3% | 0.00% | 0.0% |
| Q4 2016 | $104,000 | +52.9% | 19,522 | +62.7% | 0.00% | 0.0% |
| Q3 2016 | $68,000 | -17.1% | 12,000 | -19.3% | 0.00% | 0.0% |
| Q2 2016 | $82,000 | -21.2% | 14,863 | +5.9% | 0.00% | 0.0% |
| Q1 2016 | $104,000 | -25.2% | 14,040 | -15.9% | 0.00% | -50.0% |
| Q4 2015 | $139,000 | +41.8% | 16,696 | +52.7% | 0.00% | +100.0% |
| Q3 2015 | $98,000 | -43.7% | 10,932 | -24.5% | 0.00% | -50.0% |
| Q2 2015 | $174,000 | -7.9% | 14,484 | -17.5% | 0.00% | 0.0% |
| Q1 2015 | $189,000 | +114.8% | 17,546 | +0.7% | 0.00% | +100.0% |
| Q4 2014 | $88,000 | +3.5% | 17,432 | -46.0% | 0.00% | 0.0% |
| Q3 2014 | $85,000 | -46.5% | 32,256 | -18.5% | 0.00% | -50.0% |
| Q2 2014 | $159,000 | -57.4% | 39,561 | -51.4% | 0.00% | -60.0% |
| Q1 2014 | $373,000 | +122.0% | 81,441 | +92.0% | 0.01% | +25.0% |
| Q3 2013 | $168,000 | +84.6% | 42,407 | -2.0% | 0.00% | +100.0% |
| Q2 2013 | $91,000 | – | 43,280 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
| MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
| MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
| Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
| Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
| A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
| Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
| EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |